IFNG and psoriasis: Ping Li et al. demonstrated that luteolin can relieve the lesions and symptoms of psoriasis by reversing the effect of IFN-γ, inhibiting the expression of HSP90 and exosome secretion, and regulating the proportion of immune cells through network pharmacology combined with in vitro and in vivo experimental validation (55).